Skip to main content

Peer Review reports

From: Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis

Original Submission
25 Feb 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Mar 2013 Reviewed Reviewer Report - Mark Rodgers
Resubmission - Version 3
Submitted Manuscript version 3
7 Mar 2013 Editorially accepted
28 Jun 2013 Article published 10.1186/2046-4053-2-47

You can find further information about peer review here.

Back to article page